EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease

Youjin Jung, Jessica S Damoiseaux

Brain · 04.01.2024 · 147 (1) · 12-25

DOI: 10.1093/brain/awad267 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain, online erschienen am 04.08.2023. Verfasst von Youjin Jung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Wayne State University, Detroit, MI 48202, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health, Blue Cross Blue Shield of Michigan Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past several years, there has been a surge in blood biomarker studies examining the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration for Alzheimer's disease. However, there have been limited efforts to combine existing findings to assess the utility of blood NfL as a biomarker of neurodegeneration for Alzheimer's disease. In addition, we still need better insight into the specific aspects of neurodegeneration that are reflected by the elevated plasma or serum concentration of NfL. In this review, we survey the literature on the cross-sectional and longitudinal relationships between blood-based NfL levels and other, neuroimaging-based, indices of neurodegeneration in individuals on the Alzheimer's continuum. Then, based on the biomarker classification established by the FDA-NIH Biomarker Working group, we determine the utility of blood-based NfL as a marker for monitoring the disease status (i.e. monitoring biomarker) and predicting the severity of neurodegeneration in older adults with and without cognitive decline (i.e. a prognostic or a risk/susceptibility biomarker). The current findings suggest that blood NfL exhibits great promise as a monitoring biomarker because an increased NfL level in plasma or serum appears to reflect the current severity of atrophy, hypometabolism and the decline of white matter integrity, particularly in the brain regions typically affected by Alzheimer's disease. Longitudinal evidence indicates that blood NfL can be useful not only as a prognostic biomarker for predicting the progression of neurodegeneration in patients with Alzheimer's disease but also as a susceptibility/risk biomarker predicting the likelihood of abnormal alterations in brain structure and function in cognitively unimpaired individuals with a higher risk of developing Alzheimer's disease (e.g. those with a higher amyloid-β). There are still limitations to current research, as discussed in this review. Nevertheless, the extant literature strongly suggests that blood NfL can serve as a valuable prognostic and susceptibility biomarker for Alzheimer's disease-related neurodegeneration in clinical settings, as well as in research settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansAgedNeurofilament ProteinsCross-Sectional StudiesIntermediate FilamentsAmyloid beta-PeptidesBiomarkers

Stichwörter der Autor:innen

atrophydementiaglucose metabolismwhite matter microstructure

Substanzen

Neurofilament ProteinsAmyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Department of Psychology, Wayne State University, Detroit, MI 48202, USA.
  • Institute of Gerontology, Wayne State University, Detroit, MI 48202, USA.

Förderung

  • NIA NIH HHS
  • National Institutes of Health
  • Blue Cross Blue Shield of Michigan Foundation

Zitieren

APA

Jung, Y., & Damoiseaux, J. S. (2024). The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease. Brain, 147(1), 12-25. https://doi.org/10.1093/brain/awad267

Vancouver

Jung Y, Damoiseaux JS. The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease. Brain. 2024;147(1):12-25. doi:10.1093/brain/awad267

BibTeX
@article{Jung2024,
  author = {Jung, Youjin and Damoiseaux, Jessica S},
  title = {The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {1},
  pages = {12--25},
  doi = {10.1093/brain/awad267}
}
Kostenlos starten →